Search Results for: NANOTECHNOLOGY MARKET Nanotechnology Markets in


November 19, 2014

NANOTECHNOLOGY MARKETNanotechnology Markets in Healthcare & Medicine November 19, 2014

Kevin James, Jackson Highsmith, and Paul Evers report the global market for nanoparticles in the life sciences is estimated at over $29.6 billion for 2014. This market is forecast to grow to more than $79.8 billion by 2019, to register a healthy compound annual growth rate of 22%. The biggest increase will come in the area of drug delivery systems.

November 19, 2015

DRUG DEVICE MARKET – Joining Forces: Global Markets for Drug-Device Combinations November 19, 2015

Kevin James and Kevin Gainer of BCC Research indicate the development of the market for combination products is closely related to the drug delivery systems sector, which represents a vast area of research and the demand for sophisticated drug delivery devices behind many novel product developments.

March 3, 2015

MARKET BRIEF – Miniaturizing Healthcare – From Microelectronics to Nanobiosensing March 3, 2015

Cecilia Van Cauwenberghe, MS, Technical Insights Senior Research Analyst, Frost & Sullivan, reports that the proliferation of lower cost microfluidics-based genomics tools offering improved capabilities and allowing more access to end-users is expected to drive this technology for pharmaceutical and biomedical research throughout the next 5 years.

November 19, 2014

GLOBAL DELIVERY MARKET – Advanced Drug Delivery Systems: mAb, RNAi, & Breaking the Blood-Brain Barrier November 19, 2014

Kevin James, Shalini Dewan, MS, Kim Lawson, and Usha Nagavarapu believe advances in understanding human biology and diseases are opening new and exciting possibilities in the biotechnology industry. R&D spending, along with increasing competition, patent expiries, and new and emerging technologies will continue to shape growth in this market for the foreseeable future.

November 23, 2020

FORMULATION FORUM – Age-Appropriate Pediatric Formulation Development November 23, 2020

Jim Huang, PhD, reviews how a pediatric formulation should consider the following factors: difference in physiological and pharmacokinetic of patient populations, dosage form selection, route of administration, dose accuracy, dose flexibility, drug and excipient tolerability (safety and toxicity), patient compliance (palatability/swallowability), stability, and drug accessibility.

January 24, 2020

Ritter Pharmaceuticals & Qualigen Announce Merger Agreement January 24, 2020

Ritter Pharmaceuticals, Inc. recently reported it has entered into a definitive reverse merger agreement with Qualigen, Inc. as well as expansion of its flagship FastPack diagnostic platform, whereby a wholly owned…..

November 29, 2012

12/5/2012 November 29, 2012

Curis Announces Several Major Announcements Curis, Inc. recently announced it has licensed from Genentech, a member of the Roche Group,...
July 30, 2012

8/1/2012 July 30, 2012

BD Launches Thin-Wall Needle Technology BD Medical recently announced the launch of the BD Hyflow needle, a unique 27-gauge thin-wall...
May 8, 2018

About us

Drug Development & Delivery, including its exclusive Specialty Pharma section, is a print publication, conference organizer (Drug Development Networking Summit),...


May 2, 2018

Vol. 7 No. 8 September – 2007

The Future of Dissolvable Films Scott D. Barnhart, MS, and Martha S. Sloboda, MBA, outline the next generation of films,...
May 2, 2018

April 2008

Financing the Purchase: Where Will it Come From? Derrek G. Hennecke, MBA, continues with part 3 of his 7-part series...
May 2, 2018

September 2008

The Deal Derrek G. Hennecke, MBA, concludes his 7-part series chronicling the challenges, issues, and more importantly, the opportunities he...